General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Cardiac Community Core Lab, LLC(MODEST), Springer Publishing(MODEST), Genomics, Inc(MODEST), Sequana Medical, AV(MODEST), Zehna Therapeutics, LLC(MODEST), Renovacor, Inc(MODEST), Boston Scientific(MODEST), CardiaTec Biosciences(MODEST), Intellia Therapeutics(MODEST), Kiniksa Pharmaceuticals(MODEST), WhiteSwell Inc(MODEST), Cardiol Therapeutics, Inc(MODEST) RESEARCH/RESEARCH GRANTS: Applied Therapeutics, Inc(NONE), Second Heart Assist, Inc(NONE), Alnylam Pharmaceuticals(NONE), Salubris Biotherapeutics, Inc.(NONE), Cordio Medical Ltd(NONE), BioCardia Inc(NONE), Bristol-Myers Squibb Company (NONE), Tenaya Therapeutics Inc(NONE), Cardurion Inc(NONE), AstraZeneca Pharmaceuticals(NONE) OTHER FINANCIAL BENEFIT: Belvoir Media Group(MODEST)

View Full Disclosure